Skip to main content
Top
Published in: BMC Clinical Pathology 1/2013

Open Access 01-12-2013 | Research article

Pre-operative hypoalbuminaemia predicts poor overall survival in rectal cancer: a retrospective cohort analysis

Authors: Pramodh C Chandrasinghe, Dileepa S Ediriweera, Sumudu K Kumarage, Kemal I Deen

Published in: BMC Clinical Pathology | Issue 1/2013

Login to get access

Abstract

Background

Serum albumin is a marker of nutrition and inflammation. It has recently emerged as a predictor of outcome after surgery for rectal cancer. Our aim was to evaluate if pre-operative serum albumin would predict survival after resection for rectal cancer.

Method

226 Patients with rectal cancer of all stages undergoing resection with curative intent were studied. Kaplan-Meier curves analysed survival based on a pre-operative albumin level of <35 g/L vs. >35 g/L. We sought for significant associations of survival with age, sex, stage, tumour site, use of neoadjuvant chemoradiation, microscopic positive resection margins, differentiation, angio, peri-neural, and lymphovascular invasion using individual variable analysis. Multifactorial analysis was performed using type III analysis with Weibull hazard model and Cox-proportional hazard model. Significance was assigned to a P value <0.05.

Results

Of 226 patients (median age- 59 years; range 19 – 88, Male - 54%), forty five (20%) had an albumin level < 35 g/L and was associated with a poor overall survival (P = 0.02). Mean survival in months for <35 g/L vs. >35 g/L was 64.7 (SE - 9.3) vs. 95.8 (SE – 7.0) and 5 year overall survival rates were 49% and 69%. Individual variable analysis revealed age, circumferential margin, stage, perineural, lympho-vascular and angio invasion to be also significant. With multifactorial analysis hypoalbuminaemia (HR = 0.58; 95% CI: 0.35 - 0.95, P = 0.03), advanced stage (HR = 2.0; 95% CI: 1.26 - 3.23, P < 0.01) and positive circumferential margin (HR = 2.2; 95% CI: 1.26 - 3.89, P < 0.01) remained significant.

Conclusion

Preoperative hypoalbuminaemia is an independent risk factor for poor overall survival in rectal cancer. Advanced tumour stage and circumferential margin positivity were the other associations with poor survival.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bistrian BR, Blackburn GL, Hallowell E, Heddle R: Protein status of general surgical patients. JAMA. 1974, 230: 858-860. 10.1001/jama.1974.03240060028025.CrossRefPubMed Bistrian BR, Blackburn GL, Hallowell E, Heddle R: Protein status of general surgical patients. JAMA. 1974, 230: 858-860. 10.1001/jama.1974.03240060028025.CrossRefPubMed
2.
go back to reference Berstein LH, Leukhardt-Fairfield CJ, Pleban W, Rudolph R: Usefulness of data on albumin and prealbumin concentrations in determining effectiveness of nutritional support. Clin Chem. 1989, 35: 271-274. Berstein LH, Leukhardt-Fairfield CJ, Pleban W, Rudolph R: Usefulness of data on albumin and prealbumin concentrations in determining effectiveness of nutritional support. Clin Chem. 1989, 35: 271-274.
3.
go back to reference Anderson CF, Wochos DN: The utility of serum albumin values in the nutritional assessment of hospitalized patients. Mayo Clin Proc. 1982, 57 (3): 181-184.PubMed Anderson CF, Wochos DN: The utility of serum albumin values in the nutritional assessment of hospitalized patients. Mayo Clin Proc. 1982, 57 (3): 181-184.PubMed
4.
go back to reference Gehring N, Imoberdorf R, Wegmann M, Rühlin M, Ballmer PE: Serum albumin-a qualified parameter to determine the nutritional status?. Swiss Mel Wkly. 2006, 136 (41–42): 664-669. Gehring N, Imoberdorf R, Wegmann M, Rühlin M, Ballmer PE: Serum albumin-a qualified parameter to determine the nutritional status?. Swiss Mel Wkly. 2006, 136 (41–42): 664-669.
5.
go back to reference Fuhrman M, Charney P, Mueller CM: Hepatic proteins and nutrition assessment. J Am Diet Assoc. 2004, 104: 1258-1264. 10.1016/j.jada.2004.05.213.CrossRefPubMed Fuhrman M, Charney P, Mueller CM: Hepatic proteins and nutrition assessment. J Am Diet Assoc. 2004, 104: 1258-1264. 10.1016/j.jada.2004.05.213.CrossRefPubMed
6.
go back to reference Gupta D, Lis CG: Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010, 9: 69-10.1186/1475-2891-9-69.CrossRefPubMedPubMedCentral Gupta D, Lis CG: Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010, 9: 69-10.1186/1475-2891-9-69.CrossRefPubMedPubMedCentral
7.
go back to reference Kobayashi T, Teruya M, Kishiki T, Endo D, Takenaka Y, Miki K, Kobayashi K, Morita K: Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival. Dig Surg. 2010, 27 (4): 285-290. 10.1159/000280021.CrossRefPubMed Kobayashi T, Teruya M, Kishiki T, Endo D, Takenaka Y, Miki K, Kobayashi K, Morita K: Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival. Dig Surg. 2010, 27 (4): 285-290. 10.1159/000280021.CrossRefPubMed
8.
go back to reference Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K: Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007, 246: 1047-1051. 10.1097/SLA.0b013e3181454171.CrossRefPubMed Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K: Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007, 246: 1047-1051. 10.1097/SLA.0b013e3181454171.CrossRefPubMed
9.
go back to reference Roxburgh CS, McMillan DC: Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010, 6 (1): 149-163. 10.2217/fon.09.136.CrossRefPubMed Roxburgh CS, McMillan DC: Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010, 6 (1): 149-163. 10.2217/fon.09.136.CrossRefPubMed
10.
go back to reference Feng C, Yao RQ, Huang FZ, Nie WP, Liu XY: Risk factors for anastomotic leakage after anterior resection for rectal cancer. Nan Fang Yi Ke Da Xue Xue Bao. 2011, 31 (5): 908-910.PubMed Feng C, Yao RQ, Huang FZ, Nie WP, Liu XY: Risk factors for anastomotic leakage after anterior resection for rectal cancer. Nan Fang Yi Ke Da Xue Xue Bao. 2011, 31 (5): 908-910.PubMed
11.
go back to reference Lohsiriwat V, Chinswangwatanakul V, Lohsiriwat S, Akaraviputh T, Boonnuch W, Methasade A, Lohsiriwat D: Hypoalbuminemia is a predictor of delayed postoperative bowel function and poor surgical outcomes in right-sided colon cancer patients. Asia Pac J Clin Nutr. 2007, 16: 213-217.PubMed Lohsiriwat V, Chinswangwatanakul V, Lohsiriwat S, Akaraviputh T, Boonnuch W, Methasade A, Lohsiriwat D: Hypoalbuminemia is a predictor of delayed postoperative bowel function and poor surgical outcomes in right-sided colon cancer patients. Asia Pac J Clin Nutr. 2007, 16: 213-217.PubMed
12.
go back to reference Lai CC, You JF, Yeh CY, Chen JS, Tang R, Wang JY, Chin CC: Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis. 2011, 26 (4): 473-481. 10.1007/s00384-010-1113-4.CrossRefPubMed Lai CC, You JF, Yeh CY, Chen JS, Tang R, Wang JY, Chin CC: Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis. 2011, 26 (4): 473-481. 10.1007/s00384-010-1113-4.CrossRefPubMed
13.
go back to reference Lohsiriwat V, Lohsiriwat D, Boonnuch W, Chinswangwatanakul V, Akaraviputh T, Lert-akayamanee N: Pre-operative hypoalbuminemia is a major risk factor for postoperative complications following rectal cancer surgery. World J Gastroenterol. 2008, 14 (8): 1248-1251. 10.3748/wjg.14.1248.CrossRefPubMedPubMedCentral Lohsiriwat V, Lohsiriwat D, Boonnuch W, Chinswangwatanakul V, Akaraviputh T, Lert-akayamanee N: Pre-operative hypoalbuminemia is a major risk factor for postoperative complications following rectal cancer surgery. World J Gastroenterol. 2008, 14 (8): 1248-1251. 10.3748/wjg.14.1248.CrossRefPubMedPubMedCentral
14.
go back to reference Carruthers R, Tho LM, Brown J, Kakumanu S, McCartney E, McDonald AC: Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis. 2012, 14 (10): e701-e707. 10.1111/j.1463-1318.2012.03147.x.CrossRefPubMed Carruthers R, Tho LM, Brown J, Kakumanu S, McCartney E, McDonald AC: Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis. 2012, 14 (10): e701-e707. 10.1111/j.1463-1318.2012.03147.x.CrossRefPubMed
15.
go back to reference Wijenayake W, Perera M, Balawardena J, Deen R, Wijesuriya SR, Kumarage SK, Deen KI: Proximal and distal rectal cancers differ in curative resectability and local recurrence. World J Gastrointest Surg. 2011, 3 (8): 113-118. 10.4240/wjgs.v3.i8.113.CrossRefPubMedPubMedCentral Wijenayake W, Perera M, Balawardena J, Deen R, Wijesuriya SR, Kumarage SK, Deen KI: Proximal and distal rectal cancers differ in curative resectability and local recurrence. World J Gastrointest Surg. 2011, 3 (8): 113-118. 10.4240/wjgs.v3.i8.113.CrossRefPubMedPubMedCentral
16.
go back to reference Heys SD, Walker LG, Deehan DJ, Eremin OE: Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb. 1998, 43 (3): 163-168.PubMed Heys SD, Walker LG, Deehan DJ, Eremin OE: Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb. 1998, 43 (3): 163-168.PubMed
17.
go back to reference Aamodt R, Bondi J, Andersen SN, Bukholm G, Bukholm IRK: Expression of nuclear beta catenin in rectal versus colonic cancers. Open Clin Cancer J. 2008, 2: 13-17. 10.2174/1874189400802010013.CrossRef Aamodt R, Bondi J, Andersen SN, Bukholm G, Bukholm IRK: Expression of nuclear beta catenin in rectal versus colonic cancers. Open Clin Cancer J. 2008, 2: 13-17. 10.2174/1874189400802010013.CrossRef
18.
go back to reference Bautista CV, Felis CP, Espinet JM, García JB, Salas JV: Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer. Dis Colon Rectum. 2007, 50 (5): 611-620. 10.1007/s10350-006-0820-y.CrossRefPubMed Bautista CV, Felis CP, Espinet JM, García JB, Salas JV: Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer. Dis Colon Rectum. 2007, 50 (5): 611-620. 10.1007/s10350-006-0820-y.CrossRefPubMed
19.
go back to reference Schindl M, Wigmore SJ, Currie EJ, Laengle F, Garden OJ: Prognostic scoring in colorectal cancer liver metastases: development and validation. Arc Surg. 2005, 140 (2): 183-189. 10.1001/archsurg.140.2.183.CrossRef Schindl M, Wigmore SJ, Currie EJ, Laengle F, Garden OJ: Prognostic scoring in colorectal cancer liver metastases: development and validation. Arc Surg. 2005, 140 (2): 183-189. 10.1001/archsurg.140.2.183.CrossRef
20.
go back to reference Neal CP, Mann CD, Sutton CD, Garcea G, Ong SL, Steward WP, Dennison AR, Berry DP: Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases. Eur J Cancer. 2009, 45 (1): 56-64. 10.1016/j.ejca.2008.08.019.CrossRefPubMed Neal CP, Mann CD, Sutton CD, Garcea G, Ong SL, Steward WP, Dennison AR, Berry DP: Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases. Eur J Cancer. 2009, 45 (1): 56-64. 10.1016/j.ejca.2008.08.019.CrossRefPubMed
21.
go back to reference McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS: Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007, 22 (8): 881-886. 10.1007/s00384-006-0259-6.CrossRefPubMed McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS: Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007, 22 (8): 881-886. 10.1007/s00384-006-0259-6.CrossRefPubMed
22.
go back to reference Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS, Foulis AK, Horgan PG, McMillan DC: A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011, 47 (17): 2633-2641. 10.1016/j.ejca.2011.03.028.CrossRefPubMed Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS, Foulis AK, Horgan PG, McMillan DC: A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011, 47 (17): 2633-2641. 10.1016/j.ejca.2011.03.028.CrossRefPubMed
23.
go back to reference Rubin H, Carlson S, DeMeo M, Ganger D, Craig RM: Randomized, double-blind study of intravenous human albumin in hypoalbuminemic patients receiving total parenteral nutrition. Crit Care Med. 1997, 25: 249-252. 10.1097/00003246-199702000-00009.CrossRefPubMed Rubin H, Carlson S, DeMeo M, Ganger D, Craig RM: Randomized, double-blind study of intravenous human albumin in hypoalbuminemic patients receiving total parenteral nutrition. Crit Care Med. 1997, 25: 249-252. 10.1097/00003246-199702000-00009.CrossRefPubMed
24.
go back to reference Woods MS, Kelley H: Oncotic pressure, albumin and ileus: the effect of albumin replacement on postoperative ileus. Am Surg. 1993, 59: 758-763.PubMed Woods MS, Kelley H: Oncotic pressure, albumin and ileus: the effect of albumin replacement on postoperative ileus. Am Surg. 1993, 59: 758-763.PubMed
Metadata
Title
Pre-operative hypoalbuminaemia predicts poor overall survival in rectal cancer: a retrospective cohort analysis
Authors
Pramodh C Chandrasinghe
Dileepa S Ediriweera
Sumudu K Kumarage
Kemal I Deen
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Clinical Pathology / Issue 1/2013
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/1472-6890-13-12

Other articles of this Issue 1/2013

BMC Clinical Pathology 1/2013 Go to the issue

Reviewer acknowledgement

Reviewer acknowledgements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine